Article Type
Changed
Tue, 02/14/2023 - 13:05

Mounting evidences suggests that a high carbohydrate diet is associated with a higher risk of mortality. Also today, from MDedge Pediatrics, a consult on influenza and pneumonia, brodalumab beats ustekinumab to PASI 100, and a novel agent cuts LDL in patients who are intolerant to statins.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Topics
Sections

Mounting evidences suggests that a high carbohydrate diet is associated with a higher risk of mortality. Also today, from MDedge Pediatrics, a consult on influenza and pneumonia, brodalumab beats ustekinumab to PASI 100, and a novel agent cuts LDL in patients who are intolerant to statins.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Mounting evidences suggests that a high carbohydrate diet is associated with a higher risk of mortality. Also today, from MDedge Pediatrics, a consult on influenza and pneumonia, brodalumab beats ustekinumab to PASI 100, and a novel agent cuts LDL in patients who are intolerant to statins.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica